Skip to content
Stock screener

ZBH Zimmer Biomet Holdings, Inc. stock chart & analysis

Conviction 31HealthcareScan · Fri, Nov 6, 2026

Zimmer Biomet Holdings, Inc. (ZBH) closed at $105.59 (-1.18%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 85, -6.2% from its 52-week high, +17.4% year to date. Sector: Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies.

ZBH$105.59-1.18%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Zimmer Biomet Holdings, Inc.Orthopedic, Prosthetic & Surgical Appliances & Supplieswww.zimmerbiomet.com ↗
Price105.59
Change-1.18%
Gap-3.24%
Rel volume0.70×
Avg volume2.36M
Avg $ vol232.69M
SMA 2097.37
SMA 5095.12
SMA 20092.03
Price vs 50+10.98%
Price vs 200+14.70%
MA stackbullish
50/200 cross—
Supertrendup · 96.75
RSI (14)64
MACD hist1.22
MACD cross—
Stoch %K / %D62 / 73
ADX (14)23
+DI / −DI39 / 15
RSI divergence—
MACD divergence—
ATR %3.31%
ADR %2.95%
52w high112.55
52w low79.12
From 52w high-6.20%
Above 52w low+33.42%
New 52w highNo
SqueezeOff
Bollinger width19.48%
%B0.93
Donchian pos70.13%
Donchian high112.55
Donchian low89.18
AVWAP (52w high)107.57
vs AVWAP high-1.87%
AVWAP (52w low)92.52
vs AVWAP low+14.10%
OBV trendFlat
Chaikin MF (20)0.17
Today vs 20d0.70×
Avg vol (14d)2.58M
Avg vol (20d)2.36M
Avg $ vol (20d)232.69M
Market cap19.98B
RS Rating85 / 99
RS 3m (vs SPY)+12.83%
RS 6m (vs SPY)+28.52%
RS line new highNo
Trend template6/8
Technical rank93.6
1 week+11.69%
1 month+18.77%
3 months+7.96%
6 months+28.22%
1 year+20.58%
YTD+17.40%
P/E28.33
P/B1.57
P/S2.43
P/FCF13.57
EPS3.55
Div yield0.95%
ROE5.55%
ROA3.00%
Debt/Eq0.59
Current1.46
EV/EBITDA12.36
Gross margin69.71%
Net margin8.57%
Rev growth7.20%
EPS growth-21.98%
Price target114.00
Target upside7.99%
Analyst ratingHold
Institutional117.80%
Ent. value27.08B
Revenue2.06B
Net income191.6M
Gross profit1.47B
Free cash flow1.47B
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNYSE
Shares out193.46M
Employees17K
ListedTue, Aug 7, 2001
Free float195.42M
Float %99.9%
Short interest—
Days to cover—
Short volume55.9%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.90 vs $1.89
Last surprise+0.5% beat
Setup gradeD
Conviction31 / 100
Pattern quality—
Tech rank93.6 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance105.93
Support87.21
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

ZBH technical analysis

Trend

ZBH is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 11.0% above the 50-day ($95.12) and 14.7% above the 200-day ($92.03). ADX(14) at 23 points to a moderate trend. It meets 6 of 8 trend-template criteria.

Momentum

RSI(14) is 64, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 85 puts its weighted 12-month performance ahead of about 85% of the US market.

Volume and volatility

Volume on the latest session ran 0.7× its 20-day average. It trades about $232.7M a day on average. ATR(14) is $3.50, 3.3% of price — its typical daily range. Chaikin Money Flow (0.17) shows accumulation.

Key levels

The chart pattern's support is $87.21 and its resistance $105.93. The 52-week range is $79.12 to $112.55; price is 6.2% below the high and 33.4% above the low. The VWAP anchored at the 52-week high is $107.57, above price.

Performance

ZBH returned +11.7% (1 week), +18.8% (1 month), +8.0% (3 months), +28.2% (6 months), +20.6% (1 year), +17.4% (year to date).

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Listed 2001 · 17,000 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 28 – Oct 9
    4 scans
  2. Broke out
    Oct 13
    1 scan
  3. Retesting breakout
    Oct 14
    1 scan
  4. Broke out
    Oct 15 – Oct 19
    3 scans
  5. Setting up
    Oct 28 – Oct 29
    2 scans
  6. Breaking out now
    Nov 4
    1 scan

Congress activity

Disclosed STOCK Act trades in ZBH · 4 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Buy$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-02-11
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in ZBH · open-market 2 sells

InsiderSideShares
Campbell Gary Craig
President, Americas · Common Stock · 2026-10-01
Exercise2.37K
Campbell Gary Craig
President, Americas · Common Stock · 2026-10-01
Tax932
Campbell Gary Craig
President, Americas · Common Stock · 2026-10-01
Exercise1.22K
Campbell Gary Craig
President, Americas · Common Stock · 2026-10-01
Tax480
Campbell Gary Craig
President, Americas · Restricted Stock Units · 2026-10-01
Exercise2.37K
Campbell Gary Craig
President, Americas · Restricted Stock Units · 2026-10-01
Exercise1.22K
Thornal Kevin R
Grp Pres-Global Business · Common Stock · 2026-09-11
Sell5.69K
Phipps Chad F
See remarks below. · Common Stock · 2026-09-04
Sell3K
Desai Chintan
President, APAC · Restricted Stock Units · 2026-08-03
Grant10.17K
Noor Jehanzeb
See remarks below. · Restricted Stock Units · 2026-06-01
Grant1.86K

SEC filings

EDGAR filings in ZBH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.